UNSPSC 51434101: Azamethonium

This classification denotes an antihypertensive agent with the molecular formula C13H33N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 43XK6AW58D, chemically known as ((methylimino)diethylene)bis(ethyldimethylammonium) but generally known as azamethonium, which bears US NIH Compound Identifier 9383. European Medicines Agency schedules Azamethonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21910. The term AZAMETHONIUM is an International Non-Proprietary Name.

As of Q4 2014, AZAMETHONIUM remains the US FDA Preferred Term for this commodity. Azamethonium bears US NLM identifiers UMLS ID C2346893 and NCI Concept Code C73610. SMILES: CC[N+](C)(C)CCN(C)CC[N+](C)(C)CC.

UNSPSC 51434101 Azamethonium, a Commodity code, encompasses emergency and critical-care injectable medications supplied to state and local public-safety and healthcare agencies. Recent solicitation activity shows state and local governments buying specific advanced life support medications — epinephrine, labetalol, adenosine, diltiazem, and related injectables — for use by fire rescue services, hospitals, and emergency medical systems. The work involves supplying pharmaceuticals in bulk unit quantities with strict expiration-date warranties, rapid fulfillment timelines (typically ten calendar days from order), and compliance with OSHA Hazard Communication Standards and federal accessibility requirements. Issuing bodies include city purchasing departments and county-level public-safety agencies; the code shows limited recent posting activity, with the available opportunity sourced from a municipal fire rescue operation.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026 — a past-due opportunity — for supply to Tampa Fire Rescue in Hillsborough County, Florida. The solicitation specified 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with an estimated contract value of $40,000.00 and a one-year initial term plus renewal and extension options. The IFB included a Small Local Business Enterprise (SLBE) sheltered-market designation with a 5 percent bid discount capped at $10,000 and required vendors to meet WCAG 2.2 Level AA accessibility standards and Section 508 compliance. Recent activity under this code is sparse; no additional state or local opportunities are evident in the source.